KaloBios Pharmaceuticals, Inc. Presents Clinical Results With Anti-GM-CSF Antibody in Persistent Asthma Data From KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting
2/27/2013 9:26:32 AM
More...
|
Dyax Corp. (DYAX) Release: KALBITOR® (ecallantide) Data Presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
3/6/2012 6:24:25 AM
More...
|
Smoke Exposure Late in Pregnancy Might Boost Baby's Eczema Risk, American Academy of Allergy, Asthma and Immunology (AAAAI) Reveals
3/5/2012 7:20:09 AM
More...
|
Baxter International, Inc. (BAX) Presents Long-Term Data on HyQ During American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
3/5/2012 6:08:13 AM
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Highlights BEPREVE(R) Clinical Data at the 2011 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
3/23/2011 8:48:52 AM
More...
|
Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce RHUCIN Poster at American Academy of Allergy, Asthma and Immunology (AAAAI) 2011 Annual Meeting
3/21/2011 8:08:43 AM
More...
|
Oral Treatment Best for Milk Allergy, Finds American Academy of Allergy, Asthma and Immunology (AAAAI) Study
3/21/2011 6:28:18 AM
More...
|
Dyax Corp. (DYAX)'s KALBITOR(R) (ecallantide) Data Presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
3/2/2010 10:57:34 AM
More...
|
Data from Two Phase III Studies of Merck & Co., Inc. (MRK)'s Investigational Asthma Drug Presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
3/2/2010 10:34:47 AM
More...
|
CyDex Pharmaceuticals Presents Phase 2 Clinical Trial Results for Captisol-Enabled(R) Budesonide/Azelastine Combination Solution Nasal Spray at American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting
3/16/2009 10:41:21 AM
More...
|
|